Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1983 Oct;72(4):1511–1515. doi: 10.1172/JCI111108

Factors associated with humoral hypercalcemia of malignancy stimulate adenylate cyclase in osteoblastic cells.

S B Rodan, K L Insogna, A M Vignery, A F Stewart, A E Broadus, S M D'Souza, D R Bertolini, G R Mundy, G A Rodan
PMCID: PMC370436  PMID: 6685137

Abstract

The culture media of three cell lines, a human prostate carcinoma (PC3), a rat Leydig cell tumor (Rice-500), and a rat carcinosarcoma (WRC-256), that were derived from tumors associated with humoral hypercalcemia of malignancy (HHM), were examined for stimulation of adenylate cyclase in ROS 17/2.8 osteoblastic cells and for bone resorptive activity in culture. Cells from a nonhypercalcemic variant of the WRC256 tumor served as control. Extracts from three solid human tumors, a lung adenocarcinoma from a patient with HHM and two adenocarcinoma from normocalcemic patients (lung and colon), were also examined for adenylate cyclase stimulation. We found excellent correlation between stimulation of cyclic AMP accumulation in ROS 17/2.8 cells and bone resorbing activity in culture, or production of HHM in vivo. Stimulation of adenylate cyclase by HHM factors was inhibited by the parathyroid hormone competitive inhibitor, [8norleucyl, 18norleucyl, 34tyrosinyl] bovine parathyroid hormone (3-34) amide.

Full text

PDF
1515

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Crawford A., Atkins D., Martin T. J. Rat osteogenic sarcoma cells: comparison of the effects of prostaglandins E1, E2, I2 (prostacyclin), 6-keto F1alpha and thromboxane B2 on cyclic AMP production and adenylate cyclase activity. Biochem Biophys Res Commun. 1978 Jun 29;82(4):1195–1201. doi: 10.1016/0006-291x(78)90313-3. [DOI] [PubMed] [Google Scholar]
  2. Kaighn M. E., Narayan K. S., Ohnuki Y., Lechner J. F., Jones L. W. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol. 1979 Jul;17(1):16–23. [PubMed] [Google Scholar]
  3. Kasuga M., Van Obberghen E., Nissley S. P., Rechler M. M. Structure of the insulin-like growth factor receptor in chicken embryo fibroblasts. Proc Natl Acad Sci U S A. 1982 Mar;79(6):1864–1868. doi: 10.1073/pnas.79.6.1864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Majeska R. J., Rodan S. B., Rodan G. A. Parathyroid hormone-responsive clonal cell lines from rat osteosarcoma. Endocrinology. 1980 Nov;107(5):1494–1503. doi: 10.1210/endo-107-5-1494. [DOI] [PubMed] [Google Scholar]
  5. Massague J., Czech M. P., Iwata K., DeLarco J. E., Todaro G. J. Affinity labeling of a transforming growth factor receptor that does not interact with epidermal growth factor. Proc Natl Acad Sci U S A. 1982 Nov;79(22):6822–6826. doi: 10.1073/pnas.79.22.6822. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. McDonnell G. D., Dunstan C. R., Evans R. A., Carter J. N., Hills E., Wong S. Y., McNeil D. R. Quantitative bone histology in the hypercalcemia of malignant disease. J Clin Endocrinol Metab. 1982 Dec;55(6):1066–1072. doi: 10.1210/jcem-55-6-1066. [DOI] [PubMed] [Google Scholar]
  7. Minne H., Raue F., Bellwinkel S., Ziegler R. The hypercalcaemic syndrome in rats bearing the Walker carcinosarcoma 256. Acta Endocrinol (Copenh) 1975 Mar;78(3):613–624. doi: 10.1530/acta.0.0780613. [DOI] [PubMed] [Google Scholar]
  8. Peck W. A., Klahr S. Cyclic nucleotides in bone and mineral metabolism. Adv Cyclic Nucleotide Res. 1979;11:89–130. [PubMed] [Google Scholar]
  9. RAISZ L. G. BONE RESORPTION IN TISSUE CULTURE. FACTORS INFLUENCING THE RESPONSE TO PARATHYROID HORMONE. J Clin Invest. 1965 Jan;44:103–116. doi: 10.1172/JCI105117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Rodan G. A., Martin T. J. Role of osteoblasts in hormonal control of bone resorption--a hypothesis. Calcif Tissue Int. 1981;33(4):349–351. doi: 10.1007/BF02409454. [DOI] [PubMed] [Google Scholar]
  11. Rodan S. B., Rodan G. A. Parathyroid hormone and isoproterenol stimulation of adenylate cyclase in rat osteosarcoma clonal cells. Hormone competition and site heterogeneity. Biochim Biophys Acta. 1981 Feb 18;673(1):46–54. [PubMed] [Google Scholar]
  12. Salomon Y., Londos C., Rodbell M. A highly sensitive adenylate cyclase assay. Anal Biochem. 1974 Apr;58(2):541–548. doi: 10.1016/0003-2697(74)90222-x. [DOI] [PubMed] [Google Scholar]
  13. Schmidt-Gayk H., Löhrke H., Fischkal A., Goerttler K., Hofmann F. Urinary cyclic AMP and bone histology in Walker carcinosarcoma: evidence of parathyroid hormone-like activity. Eur J Cancer. 1979 Oct;15(10):1211–1218. doi: 10.1016/0014-2964(79)90246-9. [DOI] [PubMed] [Google Scholar]
  14. Seyberth H. W., Bonsch G., Müller H., Minne H. W., Erlenmaier T., Strein K., Imbeck H., Mrongovius R. Prostaglandin E production and hypercalcaemia in rats bearing the Walker carcinosarcoma. Br J Cancer. 1980 Sep;42(3):455–461. doi: 10.1038/bjc.1980.258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Silve C. M., Hradek G. T., Jones A. L., Arnaud C. D. Parathyroid hormone receptor in intact embryonic chicken bone: characterization and cellular localization. J Cell Biol. 1982 Aug;94(2):379–386. doi: 10.1083/jcb.94.2.379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Stewart A. F., Horst R., Deftos L. J., Cadman E. C., Lang R., Broadus A. E. Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups. N Engl J Med. 1980 Dec 11;303(24):1377–1383. doi: 10.1056/NEJM198012113032401. [DOI] [PubMed] [Google Scholar]
  17. Stewart A. F., Insogna K. L., Goltzman D., Broadus A. E. Identification of adenylate cyclase-stimulating activity and cytochemical glucose-6-phosphate dehydrogenase-stimulating activity in extracts of tumors from patients with humoral hypercalcemia of malignancy. Proc Natl Acad Sci U S A. 1983 Mar;80(5):1454–1458. doi: 10.1073/pnas.80.5.1454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Stewart A. F., Vignery A., Silverglate A., Ravin N. D., LiVolsi V., Broadus A. E., Baron R. Quantitative bone histomorphometry in humoral hypercalcemia of malignancy: uncoupling of bone cell activity. J Clin Endocrinol Metab. 1982 Aug;55(2):219–227. doi: 10.1210/jcem-55-2-219. [DOI] [PubMed] [Google Scholar]
  19. Strewler G. J., Williams R. D., Nissenson R. A. Human renal carcinoma cells produce hypercalcemia in the nude mouse and a novel protein recognized by parathyroid hormone receptors. J Clin Invest. 1983 Mar;71(3):769–774. doi: 10.1172/JCI110825. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Troyer H., Sowers J. R., Babich E. Leydig cell tumor induced hypercalcemia in the Fischer rat: morphometric and histochemical evidence for a humoral factor that activates osteoclasts. Am J Pathol. 1982 Sep;108(3):284–290. [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES